GlassScriptPhysician profile
Krzysztof Moroz
NPI 1548374440
$148.05
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.90 · 2020: $36.80 · 2022: $21.79 · 2024: $22.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $45.93 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.44 | 2020 | |
| Tempus Ai, INC | $22.56 | 2024 | |
| Roche Diagnostics Corporation | $21.79 | 2022 | |
| Tesaro, INC. | $21.23 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $12.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krzysztof Moroz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.